XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 31, 2022
Aug. 31, 2021
Cash used by operating activities:    
Net income $ 55,267 $ 108,287
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 21,617 17,441
Amortization of financing costs 512 489
Non-cash operating lease expense 5,186 4,434
Provision for credit losses 963 510
Non-cash share-based compensation 24,114 21,800
Gain on sale of Personal Care business (1,336) (513)
Gain on the sale or disposal of property and equipment (20) (1,640)
Deferred income taxes and tax credits 3,977 (8,207)
Changes in operating capital, net of effects of acquisitions of businesses:    
Receivables (46,754) (62,604)
Inventory (77,348) (124,506)
Prepaid expenses and other current assets 575 (4,982)
Other assets and liabilities, net (2,040) (4,545)
Accounts payable 3,333 6,080
Accrued expenses and other current liabilities (43,767) (26,414)
Accrued income taxes (19,731) 16,032
Net cash used by operating activities (75,452) (58,338)
Cash (used) provided by investing activities:    
Capital and intangible asset expenditures (112,635) (23,954)
Net payments to acquire businesses, net of cash acquired (148,111) 0
Proceeds from sale of Personal Care business 1,804 44,700
Proceeds from the sale of property and equipment 20 3,208
Net cash (used) provided by investing activities (258,922) 23,954
Cash provided by financing activities:    
Proceeds from revolving loans 573,500 342,500
Repayment of line of credit (465,000) (212,500)
Proceeds from term loans 250,000 0
Repayment of long-term debt (1,900) (1,900)
Payment of financing costs (586) 0
Proceeds from share issuances under share-based compensation plans 2,934 3,133
Payments for repurchases of common stock (18,305) (110,190)
Net cash provided by financing activities 340,643 21,043
Net increase (decrease) in cash and cash equivalents 6,269 (13,341)
Cash and cash equivalents, beginning balance 33,381 45,120
Cash and cash equivalents, ending balance 39,650 31,779
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable $ 8,484 $ 2,927